Tokinolide B
CAS : 112966-16-2
Ref. 3D-MEA96616
5mg | À demander | ||
10mg | À demander | ||
25mg | À demander | ||
50mg | À demander |
Informations sur le produit
- (1′S,3Z,3aS,5R,6R)-3-Butylidene-5,6,6′,7′-tetrahydro-5-propylspiro[3H-3a,6-ethanoisobenzofuran-4(1H),1′(3′H)-isobenzofuran]-1,3′-dione
- (3'Z)-(3S,8R,3a'S,6'R)-3,3a':8,6'-Diligustilide
- (3′Z)-(3S,8R,3a'S,6′R)-3,3a′:8,6′-Diligustilide
- Spiro[3H-3a,6-ethanoisobenzofuran-4(1H),1'(3'H)-isobenzofuran]-1,3'-dione,3-butylidene-5,6,6',7'-tetrahydro-5-propyl-, [3aS-(3Z,3aa,4a,5a,6a)]-
- Spiro[3H-3a,6-ethanoisobenzofuran-4(1H),1′(3′H)-isobenzofuran]-1,3′-dione, 3-butylidene-5,6,6′,7′-tetrahydro-5-propyl-, (1′S,3Z,3aS,5R,6R)-
- Spiro[3H-3a,6-ethanoisobenzofuran-4(1H),1′(3′H)-isobenzofuran]-1,3′-dione, 3-butylidene-5,6,6′,7′-tetrahydro-5-propyl-, [3aS-(3Z,3aα,4α,5α,6α)]-
Tokinolide B is a dietary supplement that is used to treat various nervous system and inflammatory diseases. This agent has been shown to inhibit the activity of the progesterone receptor, which may be due to its inhibition of fatty acid synthesis. Tokinolide B also inhibits the activity of the ligustilide-sensitive receptor, which is responsible for the transmission of nerve impulses. The biological properties of this drug have been shown in studies on humans, where it was shown to have an inhibitory effect on fatty acids and organic acids.
Propriétés chimiques
Question d’ordre technique sur : 3D-MEA96616 Tokinolide B
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages